Vietnam Diagnostic and Monitoring Devices Market Size and Forecast by Offering, Technology, Clinical Application, Distribution Channel, and End User: 2019-2033

---

Industry Assessment Overview

Industry Findings: National digital-health and registration reforms are the dominant structural drivers, forcing suppliers to invest in local regulatory dossiers and distribution partnerships. Vietnam’s Decision 5316 (medical digitalisation roadmap to 2025/2030) frames government plans to scale EMR and telehealth capacity, prompting hospitals to require devices that support national-level data flows and remote monitoring integration (Decision referenced 2020; implementation activity visible through 2023–2024). This encourages vendors to prioritise interoperability and localisation.

Industry Progression: The Ministry’s move toward a formal medical-device law and regulation updates culminated in draft updates circulated in Aug-2024, clarifying registration categories and reducing uncertainty for many device classes. That policy action directly accelerated distributor-led campaigns and vendor investments in regulatory dossiers, enabling faster deployments when tenders or hospital projects moved from planning into procurement in 2024–2025.

Industry Player Insights: The market in Vietnam consists of numerous players, including Abbott, Roche Diagnostics, GE HealthCare, and Vimedimex etc. Commercial momentum is visible in partnerships and channel expansions: GE HealthCare’s expanded strategic partnership with local IT firm FPT to accelerate AI and digital solutions (Apr-2025) and Vimedimex’s continuing role as a major distributor (exhibitor and market organiser activity 2024–2025) illustrate how global vendors partner with local channels to speed hospital adoption of imaging, lab automation and monitoring equipment.